Cornerstone (CRTX) Receives FDA Approval for Bethkis NDA; Currently in Licensing Talks
Tweet Send to a Friend
On October 12, 2012, the U.S. Food and Drug Administration (the "FDA") approved the New Drug Application by Chiesi Farmaceutici ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
